These three stocks, which are at or near the top of their respective industries, increased their earnings by double-digit percentages. Below, I’ll reveal how much these companies are paying shareholders now. I’ll also touch on notable stock buyback news. Additionally, I will provide an update on key proposed legislation that investors should be aware of regarding one of these companies.
PACCAR: +4% yield makes it one of the best companies in terms of industry dividends
PACCAR Dividend Payments
- Dividend yield
- 1.15%
- Annual profits
- $1.20
- Annual earnings growth for 3 years
- 6.82%
- Dividend distribution ratio
- 13.41%
- Upcoming dividend payment
- January 8
PCAR Earnings History
Bakkar Nasdaq: Picardcommercial truck manufacturer, Increased profits by 10%. The new dividend of $0.33 per share will be paid on March 5 to shareholders of record as of February 12. The company has a history of rewarding shareholders with large dividend payments relative to its profits. The average quarterly payout ratio over the past five years is approximately 51%. The new dividend gives the company a stated dividend yield of 4.1% in 2025. The indicated dividend yield measurement assumes that the dividend amount does not change over the course of the year.
Despite distributing small quarterly dividends, the company reaches this number because it often announces a large additional dividend at the end of each year. In 2024, the additional payment is $3.00 per share. In 2023, it’s even higher at $3.20 per share. This 4.1% yield is high compared to the 1.2% offered by the SPDR S&P 500 ETF Trust NYSEARCA: SPY. The company’s indicated yield is also in the top six among large U.S. and Canadian industrial stocks.
Eli Lilly: Pharma giant raises its profits by double and announces buybacks
Eli Lilly and the company’s dividend payments
- Dividend yield
- 0.77%
- Annual profits
- $6.00
- Annual earnings growth for 3 years
- 15.15%
- Dividend distribution ratio
- 64.86%
- Upcoming dividend payment
- March 10
LLY Dividend Date
Eli Lilly New York Stock Exchange: LLYThe largest pharmaceutical stock in the world by market value, Just announced a big raise In its quarterly profits. The 15% increase comes, and it is the seventh year in a row that the company has raised its profits by this number. On March 10, 2025, shareholders of record after February 14 will receive a payment of $1.50 per share.
In addition to this dividend increase, the company also announced that it authorized a $15 billion stock buyback program. Based on a market capitalization of $691 billion as of the December 20 close, this buyback program represents 2% of the company’s value. Although the buyback program is relatively small in size, it is three times larger than the previous program.
Based on a December 20 closing price of just under $768, the company’s indicated dividend yield is about 0.8% for 2025. Although the number is small, it actually beats most of its industry. Of the 43 large pharmaceutical and biotech stocks in the US, Canada and Europe, Lilly’s dividend yield is higher than 53%. Of these 43 stocks, 21 do not pay dividends at all.
MasterCard: Good news on dividends, buybacks and credit card regulation
MasterCard Dividend Payments
- Dividend yield
- 0.50%
- Annual profits
- $2.64
- Increasing track record profits
- 13 years old
- Annual earnings growth for 3 years
- 12.53%
- Dividend distribution ratio
- 19.97%
- Upcoming dividend payment
- February 7
Dividend distribution date
MasterCard Payment Network Company New York Stock Exchange: MSc The company increased its quarterly profits by 15% It will pay a new dividend of $0.76 per share For shareholders of record as of January 9th on February 7th. It gives the company a specified dividend yield of just under 0.6% for 2025.
Like Lilly, MasterCard authorized a significant stock buyback program. The company now has $15.9 billion in stock repurchase power. This figure combines the new figure of $12 billion with the $3.9 billion that remains from the previous buyback program. Together, this license represents more than 3% of the company’s market cap of $485 billion as of the December 20 close.
In other Mastercard news, some concerns about regulation appear to have subsided, at least for now. In November, Visa executives and advisors New York Stock Exchange: V Mastercard attended a Senate Judiciary Committee hearing. The point was to discuss the Credit Card Competition Act (CCCA). Some lawmakers and outside analysts argue that Visa and MasterCard enjoy an unfair duopoly in the credit card market. They say a lack of competition means merchants must pay excessive swiping fees to process credit card payments.
The law would require banks to offer at least one other payment network to compete against Visa and Mastercard. This will likely result in a reduction in the volume of payments received by Visa and Mastercard, negatively impacting revenues. However, the bill has not yet been put to a vote. With two weeks until the new Congress begins its term and other more important issues on the table, that is unlikely to happen. However, the CCCA has support from both sides of the aisle, making it a case worth watching. It is possible that lawmakers will reintroduce the bill next year.
Before you consider using Mastercard, you’ll need to hear this.
MarketBeat tracks the highest-rated and best-performing research analysts on Wall Street and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches up… and Mastercard was not on the list.
While Mastercard currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View the five stocks here
As the AI market heats up, investors with a vision for AI have the potential to see real returns. Learn about the industry as a whole plus seven companies getting work done using the power of AI.
